These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15002175)
1. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment]. Mitrokhin SD Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175 [TBL] [Abstract][Full Text] [Related]
2. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Watanakunakorn C; Axelson C; Bota B; Stahl C Am J Infect Control; 1995 Oct; 23(5):306-9. PubMed ID: 8585642 [TBL] [Abstract][Full Text] [Related]
3. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin]. Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130 [TBL] [Abstract][Full Text] [Related]
4. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707 [TBL] [Abstract][Full Text] [Related]
5. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections]. García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556 [TBL] [Abstract][Full Text] [Related]
6. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel]. Dmitrieva NV; Solodovnik FI; Petukhova IN Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065 [TBL] [Abstract][Full Text] [Related]
7. [The results and characteristics of the mupirocin (Bactroban) sanative treatment of intranasal Staphylococcus carriers in a large hospital]. Lykova EA; Eremina LV; Sterkhova GV; Kozyreva SS Antibiot Khimioter; 2000; 45(6):25-8. PubMed ID: 10904806 [TBL] [Abstract][Full Text] [Related]
8. The evaluation of nasal mupirocin to prevent Staphylococcus aureus burn wound colonization in routine clinical practice. Jaspers ME; Breederveld RS; Tuinebreijer WE; Diederen BM Burns; 2014 Dec; 40(8):1570-4. PubMed ID: 24685351 [TBL] [Abstract][Full Text] [Related]
9. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
10. Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization. Soto NE; Vaghjimal A; Stahl-Avicolli A; Protic JR; Lutwick LI; Chapnick EK Infect Control Hosp Epidemiol; 1999 May; 20(5):351-3. PubMed ID: 10349956 [TBL] [Abstract][Full Text] [Related]
11. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. van Rijen M; Bonten M; Wenzel R; Kluytmans J Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006216. PubMed ID: 18843708 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients. Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563 [TBL] [Abstract][Full Text] [Related]
14. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. Dupeyron C; Campillo B; Bordes M; Faubert E; Richardet JP; Mangeney N J Hosp Infect; 2002 Dec; 52(4):281-7. PubMed ID: 12473473 [TBL] [Abstract][Full Text] [Related]
15. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705 [TBL] [Abstract][Full Text] [Related]
16. Summaries for patients. Effects of antibiotic nose ointment for hospitalized patients with Staphylococcus aureus. Ann Intern Med; 2004 Mar; 140(6):I36. PubMed ID: 15023733 [No Abstract] [Full Text] [Related]
17. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636 [TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006 [TBL] [Abstract][Full Text] [Related]
19. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections? Wertheim HF; Vos MC Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Laupland KB; Conly JM Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]